|
Market Cap (10-Jun) $67,259,416 (1,589th) |
Close (30-Jun) $0.072 |
Volume (30-Jun) 290,277 |
Shortsold (26-May) 418,619 (0.18%) (406th) |
|
52w High $0.63 |
52w Low $0.200 |
P/E - |
EPS 0 |
BIO released this announcement to the ASX on 24 February 2022, 9:31. The announcement is marked as price sensitive, and is 4 page(s) in length and 1.32MB in size.
You can view all announcements from BIO and see how they appear on a price chart on the announcements page.
At the date of this announcement, BIO was 0.013% short sold according to ASIC data. It was ranked the 577th most shorted stock on the ASX. It is now ranked as the 406th most shorted stock on the ASX with 0.184% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from BIO | |
|---|---|
| Biome secures $1.2 million revolving debt facility | 28 June 2023, 8:35 |
| Biome surpasses $7m sales revenue target | 15 June 2023, 8:31 |
| Correction to Quarterly Activities Report | 20 April 2023, 10:07 |
| Ethics approval received for Biome Daily Kids clinical trial | 24 February 2022, 9:31 |
| Biome Clinical Development Update | 21 February 2022, 9:18 |
| Release of Restricted Securities from Escrow | 18 February 2022, 16:21 |
| Supplementary announcement Acne clinical trial | 14 February 2022, 8:33 |
You must be logged in to post a reply.
